CORPORATE ACCESS

IRVINE, Calif., March 02, 2018 -- ChromaDex Corporation (NASDAQ:CDXC), a science-based, integrated nutraceutical company devoted to pioneering technologies that improve the way people age, will hold a conference call on Thursday, March 8, 2018 at 4:30 p.m. Eastern...

New Human Clinical Studies Will Investigate the Role of NIAGEN® Nicotinamide Riboside in Mitochondrial Biogenesis and Systolic Heart Failure IRVINE, Calif., Feb. 20, 2018 -- ChromaDex Corporation (NASDAQ:CDXC), an integrated, science-based, nutraceutical company...

IRVINE, Calif., Feb. 16, 2018 -- ChromaDex Corporation (NASDAQ:CDXC), a science-based, integrated nutraceutical company devoted to pioneering technologies that improve the way people age is announcing that on February 13, 2018, Steve R. Allen, the Chairman of the...

Fourth Quarter 2017 Net Revenues Expected to Increase by 69% to Approximately $7.5 Million IRVINE, Calif., Feb. 12, 2018 -- ChromaDex Corporation (NASDAQ:CDXC), a science-based, integrated nutraceutical company devoted to pioneering technologies that improve the way...

Results of the Collaborative Study Provide Strong Preclinical Support for Nicotinamide Riboside Research in Alzheimer's Patients IRVINE, Calif., Feb. 08, 2018 -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving...

Chief Scientific Advisor of ChromaDex, Dr. Charles Brenner, Headlines Presentation "NAD+: What It Is, How We Lose It, and How To Boost It" IRVINE, Calif., Jan. 24, 2018 -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to...

IRVINE, Calif., Jan. 23, 2018 -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today that it has appointed Mark Friedman as General Counsel and Corporate Secretary, effective...

ChromaDex's patent portfolio covering its key ingredient in TRU NIAGEN® remains strong IRVINE, Calif., Jan. 22, 2018 -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today...

After launching in Hong Kong in September, Watsons expands TRU NIAGEN™ retail distribution to Singapore IRVINE, Calif., Jan. 08, 2018 -- ChromaDex Corp. (NASDAQ:CDXC), a fully integrated, science-based, nutraceutical company devoted to improving the way people...

New Research Suggests the Protective Benefits of NR May Lead to a New Therapeutic Option in Human Heart Failure IRVINE, Calif., Dec. 14, 2017 -- ChromaDex Corp. (NASDAQ:CDXC), a fully integrated, science-based, nutraceutical company devoted to improving the way people...